Correction to: Identifying Patients for Self-Administration of Omalizumab

. 2022 Nov 18;40(2):719. doi: 10.1007/s12325-022-02373-1

PMCID: PMC9898316 PMID: 36401056

Correction to: Adv Ther 10.1007/s12325-022-02308-w

In the original publication, the figure included spelling errors in the word ‘anaphylaxis’.

The original publication has been corrected to amend the spelling errors.

Kevin R. Murphy, Email: Kevin.Murphy@boystown.org

Tonya Winders, Email: twinders@allergyasthmanetwork.org.

Brandy Smith, Email: smithb62@gene.com.

Lauren Millette, Email: millette.lauren@gene.com.

Bradley E. Chipps, Email: bchipps@capitalallergy.com